Question 1

What is Genmab?

Accepted Answer

Genmab is a Company.

Question 2

How often does Genmab appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 36 articles.

Question 3

When was Genmab first tracked by Ergen?

Accepted Answer

First tracked on Apr 03, 2026.

Question 4

When was Genmab last mentioned in news?

Accepted Answer

Last active on Jun 15, 2026.

Question 5

What is Genmab's current news sentiment?

Accepted Answer

Aggregate sentiment score: 23 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Genmab in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Genmab?

Accepted Answer

Genmab Rina-S Ovarian Cancer Safety (Apr 13, 2026, 8 articles).

Question 8

How did the "Genmab Rina-S Ovarian Cancer Safety" event impact Genmab?

Accepted Answer

Genmab announced positive safety data from its Phase 1/2 RAINFOL-01 trial for Rina-S in combination with bevacizumab for advanced ovarian cancer, supporting further development of its investigational drug.

Question 9

How did the "Frost & Sullivan Institute Recognizes 50 Companies" event impact Genmab?

Accepted Answer

Genmab is a recipient of the 2026 Visionary Growth Leadership Best Practices Recognition, which could positively influence its brand image and investor perception.

Question 10

How did the "Global Market Daily Recap" event impact Genmab?

Accepted Answer

Genmab>>> lost 4% in one trading session, reflecting negative investor sentiment.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.